April 26, 2013 -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its results for the first quarter 2013. Revenues for the quarter totalled MSEK 528.5 (506.7), with continued momentum across the commercial portfolio and several significant advances in the pipeline.
